| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d938aa1b75b88f5a116a30536dc97b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2200-0652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2400-0439 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-502776
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-502761 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-42 |
| filingDate |
2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2560eaf2db5e0082fb11ddedd43a1028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3886f35a09ab07d17cccf020ee68573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_669efffaf6c81cbb1edaad4a789192d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b893a71befcb34c57748ff6e32df381e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_524153e233577b7822d472cbab938200
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b1e1c19cabb9dbf3a731b03b099b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddd342668996c27f57df33ddc3f25c3a |
| publicationDate |
2021-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021102304-A1 |
| titleOfInvention |
System for electroporation of particles |
| abstract |
A system for cell bioprocessing and cell therapy manufacturing can include a series of microfluidic modules to enable continuous-flow end-to-end cell bioprocessing. Each module can implement a different technology, and the modules can be coupled to one another to perform various unit operations in the cell bioprocessing or cell-therapy manufacturing chain to enable direct processing of a blood or blood product sample. The system can automatically and continuously process the sample into genetically-modified lymphocytes or T cells for cellular therapy. The technologies implemented by each module in the system can include any combination of microfluidic acoustophoresis, microfluidic acoustophoretic media exchange or cell washing, and continuous-flow microfluidic electrotransfection. Modules implementing these microfluidic technologies can be interconnected with plastic tubing or with a custom manifold. |
| priorityDate |
2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |